HOXB13 suppresses wnt/β‐catenin signalling in colon cancer, hence exhibiting a tumour suppressor function in this context, but does so through inhibiting transcription of the TCF4 gene (the product of which encodes a cofactor for β‐catenin).103. This evidence concerns the gene HOXB13 and neoplasm.